oxazoles has been researched along with Experimental Neoplasms in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (66.67) | 18.7374 |
1990's | 2 (7.41) | 18.2507 |
2000's | 4 (14.81) | 29.6817 |
2010's | 2 (7.41) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors | Studies |
---|---|
Ahmed, AU; Balyasnikova, IV; Burga, R; Castro, B; Cordero, A; Fares, J; Kanojia, D; Lee-Chang, C; Lesniak, MS; Miska, J; Petrosyan, E; Ramsey, MD; Rashidi, A; Schwartz, CW; Xiao, T; Zhang, P | 1 |
Fu, L; Li, P; Ma, C; Wu, M; Xu, J; Ye, S; Zhang, Z | 1 |
Fujiki, H; Suganuma, M | 2 |
Chen, XH; Deng, ZT; Feng, T; Geng, MY; Li, J; Li, YX; Qi, X; Song, CL; Wang, P | 1 |
Chen, BM; Cheng, CM; Cheng, TL; Liao, KW; Roffler, SR; Tzou, SC | 1 |
Esumi, H; Kaminishi, M; Kunimoto, S; Lu, J; Yamazaki, Y | 1 |
Atkins, AS; Burgett, AW; Harran, PG; McKnight, SL; Wang, X; Williams, NS | 1 |
Bruno, S; McGovren, JP; Neil, GL; Penta, J; Poster, DS | 1 |
Cooney, DA; Jayaram, HN; Kensler, TW | 1 |
Kamiya, S; Maekawa, A; Miyahara, M; Nakadate, M; Odashima, S; Sueyoshi, S; Tanno, M | 1 |
Cooney, DA; Kensler, TW; Reck, LJ | 1 |
de Gaetano, G; Donati, MB; Mussoni, L; Poggi, A | 2 |
Sato, M; Stammer, CH | 1 |
Schmähl, D; Wiessler, M | 1 |
Hirose, M; Ito, N; Murasaki, G; Nakanishi, K; Tatematsu, M | 1 |
Bogden, AE; Houchens, DP; Johnson, RK; Neil, GL; Ovejera, AA; Sheridan, MA | 1 |
Hemsworth, GR; Jensen, KE; Kraska, AR; Wolff, JS | 1 |
Cappellacci, L; Cristalli, G; Franchetti, P; Grifantini, M; Nocentini, G; Vittori, S | 1 |
Fusetani, N; Hashimoto, K; Kato, Y; Matsunaga, S | 1 |
Huber, KR; Roberts, J; Rosenfeld, H | 1 |
Huber, KR; Mayer, EP; Mitchell, DF; Roberts, J | 1 |
Hanna, MG; Rapp, HJ; Zbar, B | 1 |
Hanna, MG; Rapp, HJ; Snodgrass, MJ; Zbar, B | 1 |
Scribner, JD; Slaga, TJ | 1 |
Bates, RG; Waddell, WJ | 1 |
4 review(s) available for oxazoles and Experimental Neoplasms
Article | Year |
---|---|
Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.
Topics: Animals; Carcinogens; Disease Progression; Enzyme Inhibitors; Humans; Marine Toxins; Mice; Models, Molecular; Neoplasms; Neoplasms, Experimental; Okadaic Acid; Oxazoles; Protein Phosphatase 1; Protein Phosphatase 2; Rats; Skin Neoplasms; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2009 |
Acivicin. An antitumor antibiotic.
Topics: Animals; Antibiotics, Antineoplastic; Glycine; Humans; Isoxazoles; Neoplasms; Neoplasms, Experimental; Oxazoles | 1981 |
[Tumor promotion by inhibitors of protein phosphatase 1 and 2A].
Topics: Animals; Antifungal Agents; Marine Toxins; Microcystins; Neoplasms, Experimental; Okadaic Acid; Oxazoles; Peptides, Cyclic; Phosphoprotein Phosphatases; Protein Phosphatase 1; Pyrans; Spiro Compounds | 1998 |
Intracellular pH.
Topics: Acid-Base Equilibrium; Animals; Biological Transport; Blood Platelets; Brain Chemistry; Carbon Dioxide; Cats; Cell Biology; Cell Membrane Permeability; Dogs; Erythrocytes; Humans; Hydrogen-Ion Concentration; Ketones; Lymphocytes; Methods; Mice; Muscles; Neoplasms, Experimental; Neurons; Oxazoles; Potassium; Rats; Sodium | 1969 |
23 other study(ies) available for oxazoles and Experimental Neoplasms
Article | Year |
---|---|
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer.
Topics: Animals; Antineoplastic Agents, Immunological; Brain Neoplasms; Cell Line, Tumor; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasms, Experimental; Neural Stem Cells; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Xenograft Model Antitumor Assays | 2022 |
Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; K562 Cells; KB Cells; Mice; Molecular Docking Simulation; Molecular Structure; Neoplasm Proteins; Neoplasms, Experimental; Oxazoles; Rhodamine 123; Signal Transduction; Structure-Activity Relationship | 2019 |
Effects of the novel vascular targeting agent MDS-11P on tumor vascularity and its antitumor activity.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Endothelial Cells; Epirubicin; Humans; Male; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Neovascularization, Pathologic; Organophosphates; Oxazoles; Prodrugs; Rats; Rats, Sprague-Dawley; Tubulin | 2011 |
Hapten-directed targeting to single-chain antibody receptors.
Topics: Aniline Mustard; Animals; Antibodies, Monoclonal; Cell Line, Tumor; Drug Delivery Systems; Gene Expression; Haptens; Immunotherapy; Injections, Intravenous; Melanoma; Mice; Neoplasms, Experimental; Oxazoles; Polyethylene Glycols; Prodrugs; Receptors, Cell Surface; Recombinant Proteins | 2004 |
Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Culture Media; Doxorubicin; Female; Humans; Mice; Mice, Inbred BALB C; Necrosis; Neoplasms, Experimental; Oxazoles; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt | 2004 |
Therapeutic anticancer efficacy of a synthetic diazonamide analog in the absence of overt toxicity.
Topics: Animals; Antineoplastic Agents; Body Weight; Drug Evaluation, Preclinical; Heterocyclic Compounds, 4 or More Rings; Mice; Molecular Mimicry; Neoplasms, Experimental; Neutropenia; Ornithine-Oxo-Acid Transaminase; Oxazoles; Transplantation, Heterologous; Treatment Outcome | 2007 |
Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
Topics: Animals; Antimetabolites, Antineoplastic; Aspartic Acid; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Line; Isoxazoles; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nucleic Acids; Organophosphorus Compounds; Orotic Acid; Oxazoles; Phosphonoacetic Acid; Pyrimidines | 1982 |
[Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (IV) (author's transl)].
Topics: Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Neoplasms, Experimental; Oxazoles; Rats; Triazenes | 1980 |
Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma.
Topics: Animals; Aspartate Carbamoyltransferase; Aspartic Acid; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Carcinoma; Drug Therapy, Combination; Glycine; Isoxazoles; Ligases; Lung Neoplasms; Neoplasms, Experimental; Organophosphorus Compounds; Oxazoles; Phosphonoacetic Acid; Pyrimidines; Rats | 1981 |
Ditazole and platelets III. Effect of ditazole on tumor-cell induced thrombocytopenia and on bleeding time in mice.
Topics: Animals; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Oxazoles; Thrombocytopenia | 1977 |
Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice.
Topics: Animals; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Oxazoles; Platelet Aggregation | 1978 |
5-Carboxamido-4-amino-3-isoxazolidone, and asparagine analogue.
Topics: Animals; Antineoplastic Agents; Aspartate-Ammonia Ligase; Carcinoma, Hepatocellular; Isoxazoles; Leukemia L1210; Leukemia, Experimental; Liver Neoplasms; Mice; Neoplasms, Experimental; Oxazoles; Oxazolidinones | 1978 |
[On the carcinogenic action of N-nitroso compounds. 6th communication: methoxymethyl-methylnitrosamine, 1-(methoxy)-ethyl-ethylnitrosamine, methoxymethyl-ethylnitrosamine, 1-(methoxy)-ethyl-methylnitrosamine, and N-nitrosooxazolidine (author's transl)].
Topics: Animals; Biotransformation; Carcinogens; Female; Lethal Dose 50; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Experimental; Nitrosamines; Nitroso Compounds; Organ Specificity; Oxazoles; Rats | 1976 |
Enhancing effect of chemicals on production of hyperplastic liver nodules induced by n-2-fluorenylacetamide in hepatectomized rats.
Topics: 2-Acetylaminofluorene; Animals; Drug Synergism; Flavonoids; Fluorenes; Hepatectomy; Liver; Liver Neoplasms; Male; Naphthalenes; Neoplasms, Experimental; Oxazoles; Phenobarbital; Polychlorinated Biphenyls; Precancerous Conditions; Rats | 1978 |
Therapy for mouse tumors and human tumor xenografts with the antitumor antibiotic AT-125.
Topics: Animals; Antibiotics, Antineoplastic; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Glycine; Humans; Isoxazoles; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Oxazoles; Transplantation, Heterologous | 1979 |
Delayed cutaneous hypersensitivity to oxazolone in mice with tumors.
Topics: Animals; Carmustine; Doxorubicin; Female; Hypersensitivity, Delayed; Leukemia, Experimental; Leukemia, Lymphoid; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Oxazoles; Oxazolone; Sarcoma 180; Skin | 1978 |
Synthesis and antitumor activity of 2-beta-D-ribofuranosyloxazole-4-carboxamide (oxazofurin).
Topics: Animals; Antineoplastic Agents; Humans; In Vitro Techniques; Mice; Neoplasms, Experimental; Oxazoles; Ribavirin; Ribose; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Calyculins, potent antitumour metabolites from the marine sponge Discodermia calyx: biological activities.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Fluorescent Antibody Technique; Marine Toxins; Neoplasms, Experimental; Ovum; Oxazoles; Porifera; Sea Urchins; Staining and Labeling; Starfish | 1988 |
Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Azo Compounds; Biological Transport; Colonic Neoplasms; Diazooxonorleucine; Drug Resistance; Glutamine; Humans; Isoxazoles; Kinetics; Leukemia P388; Lung Neoplasms; Mice; Neoplasms, Experimental; Oxazoles; Tumor Cells, Cultured | 1988 |
Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines.
Topics: Antimetabolites; Azo Compounds; Cell Cycle; Cell Line; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation, Preclinical; Glutaminase; Glutamine; Humans; Isoxazoles; Lung Neoplasms; Neoplasms, Experimental; Oxazoles | 1987 |
Histopathology of tumor regression after intralesional injection of Mycobacterium bovis., 2. Comparative effects of vaccinia virus, oxazolone, and turpentine.
Topics: Animals; Antigen-Antibody Reactions; Carcinoma, Hepatocellular; Guinea Pigs; Ketones; Liver Neoplasms; Lymph Nodes; Male; Mycobacterium bovis; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosamines; Organ Size; Oxazoles; Skin; Turpentine; Vaccinia virus | 1972 |
Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Topics: Animals; BCG Vaccine; Carcinoma, Hepatocellular; Guinea Pigs; Histiocytes; Immunotherapy; Liver Neoplasms; Lymph Nodes; Male; Mycobacterium bovis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Oxazoles; Turpentine | 1972 |
Inhibition of tumor initiation and promotion by anti-inflammatory agents.
Topics: Alcohols; Animals; Anti-Inflammatory Agents; Benz(a)Anthracenes; Croton Oil; Dexamethasone; Diterpenes; Drug Synergism; Fatty Acids; Female; Methylcholanthrene; Mice; Neoplasms, Experimental; Oxazines; Oxazoles; Oxyphenbutazone; Time Factors | 1973 |